Triclabendazole是一种苯并咪唑，与微管蛋白结合，损害细胞内运输机制，且干扰蛋白质的合成。

Triclabendazole has been used in trials studying Parasitic Disease.

Triclabendazole treatment produces percentage decreases of the fluke egg output by 15.3%, 4.3% and 36.6%, respectively, in sheep, dairy cows and heifers, these results indicate the presence of TCBZ-resistant Fasciola hepatica in sheep and cattle on this farm. [1] Triclabendazole sulphoxide (50 mg/mL) results in extensive damage to the tegument of triclabendazole-susceptible F. hepatica, whereas triclabendazole-resistant flukes shows only localized and relatively minor disruption of the tegument covering the spines. [2]

68786-66-3

C14H9Cl3N2OS

359.65

三氯苯达唑;CGA89317;三氯苯咪唑

DMSO:67 mg/mL (186.3 mM)
H2O:<1 mgml
Ethanol:<1 mgml
Powder: -20°C for 3 years
In solvent: -80°C for 2 years